Immunology

Contributing journals to this collection:
JAMA & Archives Journals

Citations 381-390 of 1311 total displayed.

Past content

Research Letters
High Incidence of Post–Lumbar Puncture Headaches in Patients With Multiple Sclerosis Treated With Natalizumab: Role of Intrathecal Leukocytes

Olaf Stüve; Petra D. Cravens; Mahendra P. Singh; Elliot M. Frohman; J. Theodore Phillips; Gina Remington; Wei Hu; Bernhard Hemmer; Michael J. Olek; Nancy L. Monson; Michael K. Racke
Arch Neurol 2007; 64: 1055-1056. [Extract] [Full text] [PDF]  

From the Centers for Disease Control and Prevention
Influenza Vaccination Coverage Among Children With Asthma—United States, 2004-05 Influenza Season

JAMA 2007; 297: 2687-2689. [Extract] [Full text] [PDF]  

Studies
Pemphigus Variant Associated With Penicillin Use: A Case-Cohort Study of 363 Patients From Israel

Anthony D. Heymann; Gabriel Chodick; Eyal Kramer; Manfred Green; Varda Shalev
Arch Dermatol 2007; 143: 704-707. [Abstract] [Full text] [PDF]  

Controversies in Neurology
Neuromyelitis Optica Is Distinct From Multiple Sclerosis

Brian G. Weinshenker
Arch Neurol 2007; 64: 899-901. [Extract] [Full text] [PDF]  

Controversies in Neurology
Neuromyelitis Optica Is a Variant of Multiple Sclerosis

Steven L. Galetta; Jeffrey Bennett
Arch Neurol 2007; 64: 901-903. [Extract] [Full text] [PDF]  

Controversies in Neurology
Is Neuromyelitis Optica Distinct From Multiple Sclerosis?: Something for "Lumpers" and "Splitters"

Elliot M. Frohman; Douglas Kerr
Arch Neurol 2007; 64: 903-905. [Extract] [Full text] [PDF]  

Controversies in Neurology
Is Neuromyelitis Optica a Distinct Entity?

E. S. Roach
Arch Neurol 2007; 64: 906. [Extract] [Full text] [PDF]  

Original Contributions
Risk of Non-Hodgkin Lymphoma and Lymphoproliferative Precursor Diseases in US Veterans With Hepatitis C Virus

Thomas P. Giordano; Louise Henderson; Ola Landgren; Elizabeth Y. Chiao; Jennifer R. Kramer; Hashem El-Serag; Eric A. Engels
JAMA 2007; 297: 2010-2017. [Abstract] [Full text] [PDF]  

The Pediatric Forum
Cost-effectiveness of Respiratory Syncytial Virus Prophylaxis With Palivizumab

Parthiv J. Mahadevia; Frank J. Malinoski
Arch Pediatr Adolesc Med 2007; 161: 519-520. [Extract] [Full text] [PDF]  

The Pediatric Forum
Cost-effectiveness of Respiratory Syncytial Virus Prophylaxis With Palivizumab—Reply

Melony E. S. Sorbero; Nahed O. ElHassan; Caroline B. Hall; Timothy P. Stevens; Andrew W. Dick
Arch Pediatr Adolesc Med 2007; 161: 520. [Extract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132